Immunovant, Inc.
IMVT • NASDAQ • Stock Fundamentals
Immunovant, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Venker, with a market cap of $7.0B.
Market Cap$7.0B
Employees207.0
CEOEric Venker
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 20, 2026 · 6 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Immunovant, Inc. FAQ
Common questions about Immunovant, Inc.
Immunovant, Inc. (IMVT) has a market capitalization of $7.0B and trades on NASDAQ.
Immunovant, Inc. has approximately 207 employees.